BriaCell receives FDA clearance for breast cancer immunotherapy trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. RGNX

Go back to BriaCell receives FDA clearance for breast cancer immunotherapy trial
(NASDAQ: BCTX) Delayed: 3.03 +0.13 (4.48%)
Previous Close $2.90    52 Week High $ 
Open $2.91    52 Week Low $ 
Day High $3.09    P/E N/A 
Day Low $2.91    EPS $ 
Volume 54,152